Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Yaowalak U-Pratya
Affiliation
Faculty of Medicine Siriraj Hospital, Mahidol University
ORCID
Career Start Year
1998
Papers
50
H Index
17
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36528979
CRISPR/Cas9 mediated approach to generate YAP-depleted human embryonic stem cell line (MUSIe002-A-1).
Stem Cell Res
2023
36753833
Generation of RUNX1c-eGFP induced pluripotent stem cell, MUSIi012-A-4, using CRISPR/Cas9.
Stem Cell Res
2023
36603353
Derivation of MUSIi016-A iPSCs from peripheral blood with blood type O Rh positive.
Stem Cell Res
2023
35033856
Derivation of the MUSIe002-A human embryonic stem cell line.
Stem Cell Res
2022
35770320
Comparison of Clinical Characteristics and Genetic Aberrations of Plasma Cell Disorders in Thailand Population.
Technol Cancer Res Treat
2022
36124999
Inhibition of O-GlcNAcase Inhibits Hematopoietic and Leukemic Stem Cell Self-Renewal and Drives Dendritic Cell Differentiation via STAT3/5 Signaling.
Stem Cells
2022
32779719
Effect of YAP/TAZ on megakaryocyte differentiation and platelet production.
Biosci Rep
2020
32018207
YAP-depleted iPSC MUSIi012-A-2 maintained all normal stem cell characteristics.
Stem Cell Res
2020
31945613
Derivation of human embryonic stem cell line MUSIe001-A from an embryo with homozygous α<sup>0</sup>-thalassemia (SEA deletion).
Stem Cell Res
2020
32791482
Generation of a serine/threonine-protein kinase LATS1 gene-edited iPSC MUSIi012-A-3.
Stem Cell Res
2020
31677524
Generation of human induced pluripotent stem cell line carrying SCN5AC2204>T Brugada mutation (MUSli009-A-1) introduced by CRISPR/Cas9-mediated genome editing.
Stem Cell Res
2019
31669974
Derivation of a MUSIi012-A iPSCs from mobilized peripheral blood stem cells.
Stem Cell Res
2019
31852542
YAP as a key regulator of adipo-osteogenic differentiation in human MSCs.
Stem Cell Res Ther
2019
31677525
Generation of a WWTR1 mutation induced pluripotent stem cell line, MUSIi012-A-1, using CRISPR/Cas9.
Stem Cell Res
2019
29167312
Inhibition of <i>O</i>-GlcNAcase Sensitizes Apoptosis and Reverses Bortezomib Resistance in Mantle Cell Lymphoma through Modification of Truncated Bid.
Mol Cancer Ther
2018
29751777
High-efficiency derivation of human embryonic stem cell lines using a culture system with minimized trophoblast cell proliferation.
Stem Cell Res Ther
2018
29486524
Labile iron pool as a parameter to monitor iron overload and oxidative stress status in β-thalassemic erythrocytes.
Cytometry B Clin Cytom
2018
29482624
One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system.
Stem Cell Res Ther
2018
29651159
Publisher Correction: Selective Tropism of Dengue Virus for Human Glycoprotein Ib.
Sci Rep
2018
29426910
Selective Tropism of Dengue Virus for Human Glycoprotein Ib.
Sci Rep
2018
27786336
The Hippo pathway regulates human megakaryocytic differentiation.
Thromb Haemost
2017
28945165
Dengue Virus and Its Relation to Human Glycoprotein IIb/IIIa Revealed by Fluorescence Microscopy and Flow Cytometry.
Viral Immunol
2017
26893154
Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage.
Cell Tissue Res
2016
27651158
Targeting Netrin-1 in glioblastoma stem-like cells inhibits growth, invasion, and angiogenesis.
Tumour Biol
2016
27465155
Generation of induced pluripotent stem cells as a potential source of hematopoietic stem cells for transplant in PNH patients.
Ann Hematol
2016
26880942
Endothelial Progenitor Cell Migration-Enhancing Factors in the Secretome of Placental-Derived Mesenchymal Stem Cells.
Stem Cells Int
2016
26899034
Effects of mesenchymal stem cell-derived cytokines on the functional properties of endothelial progenitor cells.
Eur J Cell Biol
2016
25245632
Enhanced human mesenchymal stem cell survival under oxidative stress by overexpression of secreted frizzled-related protein 2 gene.
Ann Hematol
2015
26063314
Transdifferentiation of erythroblasts to megakaryocytes using FLI1 and ERG transcription factors.
Thromb Haemost
2015
24747566
Bortezomib enhances the osteogenic differentiation capacity of human mesenchymal stromal cells derived from bone marrow and placental tissues.
Biochem Biophys Res Commun
2014
25207966
Dual small-molecule targeting of SMAD signaling stimulates human induced pluripotent stem cells toward neural lineages.
PLoS One
2014
23176558
Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord.
Intern Med J
2013
24385773
Cardiogenic and myogenic gene expression in mesenchymal stem cells after 5-azacytidine treatment.
Turk J Haematol
2013
24163998
Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.
J Med Assoc Thai
2013
23762121
Antiproliferative Effect and the Isolated Compounds of Pouzolzia indica.
Evid Based Complement Alternat Med
2013
23467912
Cardiomyocyte differentiation of perinatallyâ¿¿derived mesenchymal stem cells.
Mol Med Rep
2013
21822618
In vitro vessel-forming capacity of endothelial progenitor cells in high glucose conditions.
Ann Hematol
2012
23243435
Significant increase in cytotoxic T lymphocytes and natural killer cells by triphala: a clinical phase I study.
Evid Based Complement Alternat Med
2012
23095789
Mechanism of paroxysmal nocturnal hemoglobinuria clonal dominance: possible roles of different apoptosis and CD8+ lymphocytes in the selection of paroxysmal nocturnal hemoglobinuria clones.
Hematol Oncol Stem Cell Ther
2012
21866566
Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus.
J Cell Biochem
2012
21808991
CD14-/CD34+ is the founding population of umbilical cord blood-derived endothelial progenitor cells and angiogenin1 is an important factor promoting the colony formation.
Ann Hematol
2012
20374643
Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic control.
BMC Endocr Disord
2010
21294413
Isolation, characterization and neural differentiation potential of amnion derived mesenchymal stem cells.
J Med Assoc Thai
2010
16409302
Impaired interaction of alpha-haemoglobin-stabilising protein with alpha-globin termination mutant in a yeast two-hybrid system.
Br J Haematol
2006
15032399
Immunophenotypic profile of adult acute myeloid leukemia (AML): analysis of 267 cases in Thailand.
Asian Pac J Allergy Immunol
2003
14696788
Collection and processing of umbilical cord blood for cryopreservation.
J Med Assoc Thai
2003
11372757
Clinical paroxysmal nocturnal hemoglobinuria is the result of expansion of glycosyl-phosphatidyl-inositol-anchored protein-deficient clone in the condition of deficient hematopoiesis.
Int J Hematol
2001
10928620
Purification of human hemopoietic stem cells for transplantation in Thailand.
Asian Pac J Allergy Immunol
2000
10998848
Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR).
J Med Assoc Thai
2000
11012154
Hematopoietic progenitor cells in the blood and bone marrow in various hematologic disorders.
Stem Cells
1998
1 - 50 of 50
Column Actions
Search
Recommended Authors
Xiaosong Huang
Guangzhou University
Career Start Year
2007
Number of shared co-authors
0
Fumio Nakahara
Graduate School of Medicine, The University of Tokyo
Career Start Year
2004
Number of shared co-authors
0
Guokai Chen
University of Macau
Career Start Year
2002
Number of shared co-authors
0
Zhaohui Ye
Center for Biologics Evaluation and Research
Career Start Year
2002
Number of shared co-authors
0
Guibin Chen
and Blood Institute, National Institutes of Health
Career Start Year
2001
Number of shared co-authors
0
Yoon-Young Jang
Daegu Catholic University Medical Center, Catholic University of Daegu
Career Start Year
1999
Number of shared co-authors
0
Bin Zhou
The Central Hospital of Shaoyang
Career Start Year
1998
Number of shared co-authors
0
Elias T Zambidis
Institute for Cell Engineering, The Johns Hopkins University School of Medicine
Career Start Year
1996
Number of shared co-authors
0
Pampee P Young
Vanderbilt University Medical Center
Career Start Year
1996
Number of shared co-authors
0
Jeanette Beers
and Blood Institute, National Institutes of Health
Career Start Year
1996
Number of shared co-authors
0
Rong Ju
Sun Yat-sen University
Career Start Year
1996
Number of shared co-authors
0
Ping Jin
Center for Cellular Engineering, National Institutes of Health Clinical Center
Career Start Year
1993
Number of shared co-authors
0
Daisuke Sugiyama
Translational Research Center, Hiroshima University
Career Start Year
1992
Number of shared co-authors
0
Yukio Nakamura
RIKEN BioResource Research Center
Career Start Year
1992
Number of shared co-authors
0
Hua Han
He Bei General Hospital
Career Start Year
1991
Number of shared co-authors
0
Claudia Giachino
University of Turin
Career Start Year
1991
Number of shared co-authors
0
Hiroshi Kawamoto
Institute for Life and Medical Sciences, Kyoto University
Career Start Year
1991
Number of shared co-authors
0
Volker Eckstein
Heidelberg University
Career Start Year
1990
Number of shared co-authors
0
Jose A Cancelas
Cincinnati Children's Hospital Medical Center
Career Start Year
1990
Number of shared co-authors
0
Linzhao Cheng
Johns Hopkins University School of Medicine
Career Start Year
1989
Number of shared co-authors
0
William L Stanford
Ottawa Hospital Research Institute
Career Start Year
1989
Number of shared co-authors
0
Dirk Strunk
Cell Therapy Institute, Paracelsus Medical University (PMU)
Career Start Year
1987
Number of shared co-authors
0
Wolfgang Wagner
Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf (CIO ABCD)
Career Start Year
1983
Number of shared co-authors
0
George Q Daley
Boston Children's Hospital, Harvard Medical School
Career Start Year
1982
Number of shared co-authors
0
David F Stroncek
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Career Start Year
1981
Number of shared co-authors
0
Anne M Dickinson
Translational and Clinical Research Institute, Newcastle University
Career Start Year
1981
Number of shared co-authors
0
Hiromitsu Nakauchi
Advanced Research Institute, Tokyo Medical and Dental University
Career Start Year
1981
Number of shared co-authors
0
Robert Deans
Synthego Corporation
Career Start Year
1978
Number of shared co-authors
0
Curt I Civin
Center for Stem Cell Biology & Regenerative Medicine and.
Career Start Year
1976
Number of shared co-authors
0
Gerhard Fritsch
AUVA Trauma Hospital Salzburg
Career Start Year
1975
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Weena Jiratchariyakul
Department of Pharmacognosy, Faculty of Pharmacy, Mahidol University
Co-authored papers
2
Sumana Dakeng
Mahidol University
Co-authored papers
2
Suwit Duangmano
Chiang Mai University
Co-authored papers
1
Oliver B??gler
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Co-authored papers
1
Pimpicha Patmasiriwat
Mahidol University
Co-authored papers
1
1 - 5